Skip to content

Clinical trials

Urogenital Neoplasms trials in France

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Urogenital Neoplasms Country / region: France Clear all

13 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20082
20091
20113
20141
20152
20221
20231
20241
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed7
Active, not recruiting2
Recruiting2
Terminated1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Steba Biotech S.A.3
Atavistik Bio, Inc1
Centre Hospitalier Universitaire de Nīmes1
Eli Lilly and Company1
LEO Pharma1
Marengo Therapeutics, Inc.1
Pfizer1
Pierre Fabre Medicament1
Promontory Therapeutics Inc.1
University Hospital, Bordeaux1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Urogenital Neoplasms13
Neoplasms7
Neoplasms by Site7
Prostatic Neoplasms7
Carcinoma5
Genital Neoplasms, Male4
Breast Neoplasms3
Male Urogenital Diseases3
Prostatic Diseases3
Carcinoma, Renal Cell2

Trials

Showing 26 to 13 of 13. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.